Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Roswell Park Cancer Institute
Roswell Park Cancer Institute
University of Michigan Rogel Cancer Center
Dana-Farber Cancer Institute
Massachusetts General Hospital
City of Hope Medical Center
City of Hope Medical Center
City of Hope Medical Center
Thomas Jefferson University
Instituto Nacional de Cancer, Brazil
St. Petersburg State Pavlov Medical University
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
City of Hope Medical Center
University of Nebraska
Melbourne Health
University of Liege
Kiadis Pharma
H. Lee Moffitt Cancer Center and Research Institute
Roswell Park Cancer Institute
University of Maryland, Baltimore
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Massachusetts General Hospital
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
Hospital Israelita Albert Einstein
University of Rochester
Mesoblast, Ltd.
City of Hope Medical Center
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Northwestern University
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins